Optiray 300 (ioversol) NDC 0019-1332

NDC codes

FDA NDC Directory

Product NDC (as listed)0019-1332Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00019-1332Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0019-1332-00	00019133200	20 SYRINGE, PLASTIC in 1 CARTON (0019-1332-00) / 100 mL in 1 SYRINGE, PLASTICMarketed from Mar 4, 2012
0019-1332-06	00019133206	25 BOTTLE, GLASS in 1 CARTON (0019-1332-06) / 50 mL in 1 BOTTLE, GLASSMarketed from Mar 4, 2012
0019-1332-11	00019133211	12 BOTTLE, GLASS in 1 CARTON (0019-1332-11) / 100 mL in 1 BOTTLE, GLASSMarketed from Mar 4, 2012
0019-1332-16	00019133216	12 BOTTLE, GLASS in 1 CARTON (0019-1332-16) / 150 mL in 1 BOTTLE, GLASSMarketed from Mar 4, 2012
0019-1332-21	00019133221	12 BOTTLE, GLASS in 1 CARTON (0019-1332-21) / 200 mL in 1 BOTTLE, GLASSMarketed from Mar 4, 2012
0019-1332-75	00019133275	20 SYRINGE, PLASTIC in 1 CARTON (0019-1332-75) / 50 mL in 1 SYRINGE, PLASTICMarketed from Mar 4, 2012
0019-1332-78	00019133278	20 SYRINGE, PLASTIC in 1 CARTON (0019-1332-78) / 50 mL in 1 SYRINGE, PLASTICMarketed from Mar 4, 2012
0019-1332-83	00019133283	20 SYRINGE, PLASTIC in 1 CARTON (0019-1332-83) / 100 mL in 1 SYRINGE, PLASTICMarketed from Mar 4, 2012
0019-1332-90	00019133290	20 SYRINGE, PLASTIC in 1 CARTON (0019-1332-90) / 100 mL in 1 SYRINGE, PLASTICMarketed from Mar 4, 2012
0019-1332-91	00019133291	20 SYRINGE, PLASTIC in 1 CARTON (0019-1332-91) / 75 mL in 1 SYRINGE, PLASTICMarketed from Mar 4, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Optiray 300Suffix: 300
Generic name (nonproprietary): ioversol
Active ingredients: Ioversol — 636 mg/mL
Dosage form: Injection
Route: Intra-arterial, Intravenous
Labeler: Liebel-Flarsheim Company LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019710
Marketing start: Mar 4, 2012
Listing expires: Dec 31, 2026
Other FDA classes: X-Ray Contrast Activity (Mechanism)
Identifiers: Product ID 0019-1332_1884aaeb-c174-4df7-a710-82d2b1869ad2SPL ID 1884aaeb-c174-4df7-a710-82d2b1869ad2SPL set ID 549d38db-d4ed-4708-8f76-7cdaa157063fUNII N3RIB7X24KUPC 0300191323521, 0300191333957, 0300191333872, 0300191323958, 0300191333902, 0300191323873, 0300191333780, 0300191323903
Pharmacologic class: Radiographic Contrast Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400019133200 followed by a unit qualifier and the quantity

Package 00019-1332-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 17, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

OPTIRAY is indicated for: OPTIRAY is a radiographic contrast agent indicated for the following: Intra-arterial Procedures ( 1.1 ) Adults: Cerebral Arteriography (300, 320 mg iodine/mL) Peripheral Arteriography (300, 320, 350 mg iodine/mL ) Visceral and Renal Arteriography, Aortography (320 mg iodine/mL) Coronary Arteriography and Left Ventriculography (320, 350 mg iodine/mL) Pediatric Patients: Angiocardiography (320, 350 mg iodine/mL) Intravenous Procedures ( 1.2 ) Adults: Computed tomography (CT) Imaging of Head and Body (300, 320, 350 mg iodine/mL) Venography (300, 320, 350 mg iodine/mL) Intravenous Excretory Urography (300, 320, 350 mg iodine/mL) Intravenous Digital Subtraction Angiograp…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 019710

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019710
Product	Strength	Form · route	Labeler	Product NDC
Optiray 320ioversol	Ioversol 678 mg/mL	InjectionIntra-arterial, Intravenous	Liebel-Flarsheim Company LLC	0019-1323
Optiray 350ioversol	Ioversol 741 mg/mL	InjectionIntra-arterial, Intravenous	Liebel-Flarsheim Company LLC	0019-1333